# FDA Inspection 1187409 - Octapharma Plasma Inc - October 14, 2022

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/e5b4e6b8-4b78-4e3a-95ef-bfda7273d176
Source feed: FDA_Inspections

> FDA Inspection 1187409 for Octapharma Plasma Inc on October 14, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1187409
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2022-10-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1187409 - 2022-10-14](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/03c53468-529b-46c1-b35e-24b96598d5e5)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/e9c108eb-6311-47de-9805-7783702c097e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d